Cargando…

Reduction in healthcare services during the COVID-19 pandemic in China

INTRODUCTION: The COVID-19 pandemic caused a healthcare crisis in China and continues to wreak havoc across the world. This paper evaluated COVID-19’s impact on national and regional healthcare service utilisation and expenditure in China. METHODS: Using a big data approach, we collected data from 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi-Na, Chen, Yun, Wang, Ying, Li, Fan, Pender, Michelle, Wang, Na, Yan, Fei, Ying, Xiao-Hua, Tang, Sheng-Lan, Fu, Chao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662138/
https://www.ncbi.nlm.nih.gov/pubmed/33184065
http://dx.doi.org/10.1136/bmjgh-2020-003421
_version_ 1783609337246121984
author Zhang, Yi-Na
Chen, Yun
Wang, Ying
Li, Fan
Pender, Michelle
Wang, Na
Yan, Fei
Ying, Xiao-Hua
Tang, Sheng-Lan
Fu, Chao-Wei
author_facet Zhang, Yi-Na
Chen, Yun
Wang, Ying
Li, Fan
Pender, Michelle
Wang, Na
Yan, Fei
Ying, Xiao-Hua
Tang, Sheng-Lan
Fu, Chao-Wei
author_sort Zhang, Yi-Na
collection PubMed
description INTRODUCTION: The COVID-19 pandemic caused a healthcare crisis in China and continues to wreak havoc across the world. This paper evaluated COVID-19’s impact on national and regional healthcare service utilisation and expenditure in China. METHODS: Using a big data approach, we collected data from 300 million bank card transactions to measure individual healthcare expenditure and utilisation in mainland China. Since the outbreak coincided with the 2020 Chinese Spring Festival holiday, a difference-in-difference (DID) method was employed to compare changes in healthcare utilisation before, during and after the Spring Festival in 2020 and 2019. We also tracked healthcare utilisation before, during and after the outbreak. RESULTS: Healthcare utilisation declined overall, especially during the post-festival period in 2020. Total healthcare expenditure and utilisation declined by 37.8% and 40.8%, respectively, while per capita expenditure increased by 3.3%. In a subgroup analysis, we found that the outbreak had a greater impact on healthcare utilisation in cities at higher risk of COVID-19, with stricter lockdown measures and those located in the western region. The DID results suggest that, compared with low-risk cities, the pandemic induced a 14.8%, 26.4% and 27.5% reduction in total healthcare expenditure in medium-risk and high-risk cities, and in cities located in Hubei province during the post-festival period in 2020 relative to 2019, an 8.6%, 15.9% and 24.4% reduction in utilisation services; and a 7.3% and 18.4% reduction in per capita expenditure in medium-risk and high-risk cities, respectively. By the last week of April 2020, as the outbreak came under control, healthcare utilisation gradually recovered, but only to 79.9%–89.3% of its pre-outbreak levels. CONCLUSION: The COVID-19 pandemic had a significantly negative effect on healthcare utilisation in China, evident by a dramatic decline in healthcare expenditure. While the utilisation level has gradually increased post-outbreak, it has yet to return to normal levels.
format Online
Article
Text
id pubmed-7662138
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76621382020-11-17 Reduction in healthcare services during the COVID-19 pandemic in China Zhang, Yi-Na Chen, Yun Wang, Ying Li, Fan Pender, Michelle Wang, Na Yan, Fei Ying, Xiao-Hua Tang, Sheng-Lan Fu, Chao-Wei BMJ Glob Health Original Research INTRODUCTION: The COVID-19 pandemic caused a healthcare crisis in China and continues to wreak havoc across the world. This paper evaluated COVID-19’s impact on national and regional healthcare service utilisation and expenditure in China. METHODS: Using a big data approach, we collected data from 300 million bank card transactions to measure individual healthcare expenditure and utilisation in mainland China. Since the outbreak coincided with the 2020 Chinese Spring Festival holiday, a difference-in-difference (DID) method was employed to compare changes in healthcare utilisation before, during and after the Spring Festival in 2020 and 2019. We also tracked healthcare utilisation before, during and after the outbreak. RESULTS: Healthcare utilisation declined overall, especially during the post-festival period in 2020. Total healthcare expenditure and utilisation declined by 37.8% and 40.8%, respectively, while per capita expenditure increased by 3.3%. In a subgroup analysis, we found that the outbreak had a greater impact on healthcare utilisation in cities at higher risk of COVID-19, with stricter lockdown measures and those located in the western region. The DID results suggest that, compared with low-risk cities, the pandemic induced a 14.8%, 26.4% and 27.5% reduction in total healthcare expenditure in medium-risk and high-risk cities, and in cities located in Hubei province during the post-festival period in 2020 relative to 2019, an 8.6%, 15.9% and 24.4% reduction in utilisation services; and a 7.3% and 18.4% reduction in per capita expenditure in medium-risk and high-risk cities, respectively. By the last week of April 2020, as the outbreak came under control, healthcare utilisation gradually recovered, but only to 79.9%–89.3% of its pre-outbreak levels. CONCLUSION: The COVID-19 pandemic had a significantly negative effect on healthcare utilisation in China, evident by a dramatic decline in healthcare expenditure. While the utilisation level has gradually increased post-outbreak, it has yet to return to normal levels. BMJ Publishing Group 2020-11-12 /pmc/articles/PMC7662138/ /pubmed/33184065 http://dx.doi.org/10.1136/bmjgh-2020-003421 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Zhang, Yi-Na
Chen, Yun
Wang, Ying
Li, Fan
Pender, Michelle
Wang, Na
Yan, Fei
Ying, Xiao-Hua
Tang, Sheng-Lan
Fu, Chao-Wei
Reduction in healthcare services during the COVID-19 pandemic in China
title Reduction in healthcare services during the COVID-19 pandemic in China
title_full Reduction in healthcare services during the COVID-19 pandemic in China
title_fullStr Reduction in healthcare services during the COVID-19 pandemic in China
title_full_unstemmed Reduction in healthcare services during the COVID-19 pandemic in China
title_short Reduction in healthcare services during the COVID-19 pandemic in China
title_sort reduction in healthcare services during the covid-19 pandemic in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662138/
https://www.ncbi.nlm.nih.gov/pubmed/33184065
http://dx.doi.org/10.1136/bmjgh-2020-003421
work_keys_str_mv AT zhangyina reductioninhealthcareservicesduringthecovid19pandemicinchina
AT chenyun reductioninhealthcareservicesduringthecovid19pandemicinchina
AT wangying reductioninhealthcareservicesduringthecovid19pandemicinchina
AT lifan reductioninhealthcareservicesduringthecovid19pandemicinchina
AT pendermichelle reductioninhealthcareservicesduringthecovid19pandemicinchina
AT wangna reductioninhealthcareservicesduringthecovid19pandemicinchina
AT yanfei reductioninhealthcareservicesduringthecovid19pandemicinchina
AT yingxiaohua reductioninhealthcareservicesduringthecovid19pandemicinchina
AT tangshenglan reductioninhealthcareservicesduringthecovid19pandemicinchina
AT fuchaowei reductioninhealthcareservicesduringthecovid19pandemicinchina